-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Relay Therapeutics, Raises Price Target to $26

Benzinga·08/10/2026 13:11:37
Listen to the news
Citizens analyst Silvan Turkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and raises the price target from $21 to $26.